XTNT - Xtant Medical Holdings Inc Stock Price, Fair Value and News

$0.600.00 (0.00%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

XTNT Price Action

Last 7 days

-3.2%

Last 30 days

-25.9%

Last 90 days

-1.6%

Trailing 12 Months

50%

XTNT RSI Chart

XTNT Valuation

Market Cap

84.0M

Price/Earnings (Trailing)

47.96

Price/Sales (Trailing)

0.63

EV/EBITDA

13.36

Price/Free Cashflow

16.12

XTNT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

XTNT Fundamentals

XTNT Revenue

Revenue (TTM)

133.1M

Rev. Growth (Yr)

19.04%

Rev. Growth (Qtr)

-6.09%

XTNT Earnings

Earnings (TTM)

1.8M

Earnings Growth (Yr)

126.04%

Earnings Growth (Qtr)

-63.15%

XTNT Profitability

EBT Margin

1.70%

Return on Equity

3.48%

Return on Assets

1.65%

Free Cashflow Yield

6.2%

XTNT Investor Care

Shares Dilution (1Y)

0.72%

Diluted EPS (TTM)

0.01

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	122.3M	127.8M	133.1M	0
2024	101.2M	110.9M	113.9M	117.3M
2023	63.0M	67.9M	78.5M	91.3M
2022	55.7M	56.0M	56.7M	58.0M
2021	51.1M	55.5M	55.3M	55.3M
2020	62.7M	58.0M	56.3M	53.3M
2019	71.0M	67.5M	66.0M	64.7M
2018	78.5M	75.8M	73.3M	72.2M
2017	91.1M	91.1M	87.8M	82.6M
2016	70.8M	82.4M	87.8M	90.0M
2015	35.9M	36.9M	46.2M	59.3M
2014	33.4M	34.0M	34.5M	35.3M
2013	33.8M	33.9M	32.9M	33.1M
2012	31.9M	32.6M	34.0M	33.0M
2011	19.1M	22.8M	26.5M	30.1M
2010	0	0	0	15.4M

Get all data in R, Python etc through our Historical Stock Data APIs

About Xtant Medical Holdings Inc

Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoFactor, which contains various proteins and peptides that support bone formation and remodeling; OsteoWrap; and OsteoVive Plus, a growth factor enriched cellular bone matrix. The company also provides 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation, Spider cervical plating, Axle interspinous fusion, Silex Sacroiliac joint fusion, Xpress minimally invasive pedicle screw, and Fortex Pedicle screw systems. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.

CEO	Mr. Sean E. Browne
WEBSITE	xtantmedical.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	134

Xtant Medical Holdings Inc Frequently Asked Questions

What is the ticker symbol for Xtant Medical Holdings Inc? What does XTNT stand for in stocks?

XTNT is the stock ticker symbol of Xtant Medical Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Xtant Medical Holdings Inc (XTNT)?

As of Wed Dec 03 2025, market cap of Xtant Medical Holdings Inc is 84 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of XTNT stock?

You can check XTNT's fair value in chart for subscribers.

Is Xtant Medical Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether XTNT is over valued or under valued. Whether Xtant Medical Holdings Inc is cheap or expensive depends on the assumptions which impact Xtant Medical Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for XTNT.

What is Xtant Medical Holdings Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, XTNT's PE ratio (Price to Earnings) is 47.96 and Price to Sales (PS) ratio is 0.63. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. XTNT PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Xtant Medical Holdings Inc's stock?

In the past 10 years, Xtant Medical Holdings Inc has provided -0.332 (multiply by 100 for percentage) rate of return.